Stelara (usetekinumab), APPROVED for plaque psoriasis

An educational resource of the Ocular Immunology and Uveitis Foundation

Home Page > Learning about Ocular Inflammatory Disease > Stelara (usetekinumab), APPROVED for plaque psoriasis	Add Reply
	<< Prev Topic \| Next Topic >>

Author	Comment
MikeBartolatz Registered User (4/1/09 11:42 pm) Reply	Stelara (usetekinumab), APPROVED for plaque psoriasis www.fda.gov/NewsEvents/Ne...183851.htm approved for moderate to severe plaque psoriasis on 25 Sept 2009 studies are also ongoing for use in Crohn's disease. other data suggests that it is 3 times as affective than Enbrel in psoriasis mike Edited by: MikeBartolatz at: 10/2/09 10:26 am
MikeBartolatz Registered User (6/10/09 2:15 pm) Reply	Re: Stelara (usetekinumab), approved for plaque psoriasis Approved in Canada and the EU for mild to severe psoriasis Edited by: MikeBartolatz at: 10/2/09 10:27 am
MikeBartolatz Registered User (9/3/09 10:50 am) Reply	Re: Stelara (usetekinumab), approved for Plaque Psoriasis www.accessdata.fda.gov/Sc...rugDetails Stelara (usetekinumab) approved for moderate to severe Plaque Psoriasis for use in the USA This is a new drug which blocks the inflammatory cytokines IL23 and IL12 which Make IL17 producing cells (TH17) which is found in many autoimmune disease processes and UVEITIS mike Edited by: MikeBartolatz at: 10/2/09 10:25 am